MIF inhibitors
The present invention relates to the use of specific benzimidazolone analogues and derivatives to inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF), and diseases or conditions wherein MIF cytokine or biological activity is implicated. Novel benzimidazole ana...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
15.04.2009
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to the use of specific benzimidazolone analogues and derivatives to inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF), and diseases or conditions wherein MIF cytokine or biological activity is implicated. Novel benzimidazole analogues and derivatives are also provided. |
|---|---|
| AbstractList | The present invention relates to the use of specific benzimidazolone analogues and derivatives to inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF), and diseases or conditions wherein MIF cytokine or biological activity is implicated. Novel benzimidazole analogues and derivatives are also provided. |
| Author | TAPLEY PETER MARK LI XINHUA MORAND ERIC FRANCIS SKENE COLIN EDWARD |
| Author_xml | – fullname: TAPLEY PETER MARK – fullname: MORAND ERIC FRANCIS – fullname: LI XINHUA – fullname: SKENE COLIN EDWARD |
| BookMark | eNrjYmDJy89L5WTg8_V0U8jMy8hMyizJLyrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBoYmQGxg7mhMjBoA84YfyA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | CN101410107A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN101410107A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:52:20 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN101410107A3 |
| Notes | Application Number: CN200680053213 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090415&DB=EPODOC&CC=CN&NR=101410107A |
| ParticipantIDs | epo_espacenet_CN101410107A |
| PublicationCentury | 2000 |
| PublicationDate | 20090415 |
| PublicationDateYYYYMMDD | 2009-04-15 |
| PublicationDate_xml | – month: 04 year: 2009 text: 20090415 day: 15 |
| PublicationDecade | 2000 |
| PublicationYear | 2009 |
| RelatedCompanies | CORTICAL PTY LTD |
| RelatedCompanies_xml | – name: CORTICAL PTY LTD |
| Score | 2.8386574 |
| Snippet | The present invention relates to the use of specific benzimidazolone analogues and derivatives to inhibit the cytokine or biological activity of macrophage... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | MIF inhibitors |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090415&DB=EPODOC&locale=&CC=CN&NR=101410107A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUq1MLEwTgEmXjOzZF2TJIMk3SQDsyRdYFs2NdXIPM3QOBE03uHrZ-YRauIVYRrBxJAF2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y0vQjnM1Fydb1wB_F39nNWdnW2c_Nb8gW0PwgkZgX8eRmYEV2Iw2B-UG1zAn0K6UAuQqxU2QgS0AaFpeiRADU1WGMAOnM-zmNWEGDl_ohDeQCc17xSIMfL6ebgqZeRmZSZmgG3JEGRTdXEOcPXSBBsfDfRHv7Idwg7EYAwuwd58qwaCQbGZokWyYaJKSagbsCqQaW6aYWpqkmqUBxYHVp4mFJIMUbnOk8ElKM3DBpj4MTWUYWEqKSlNlgTVoSZIc2OsAVZdyXQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUq1MLEwTgEmXjOzZF2TJIMk3SQDsyRdYFs2NdXIPM3QOBE03uHrZ-YRauIVYRrBxJAF2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y0vQjnM1Fydb1wB_F39nNWdnW2c_Nb8gW0PwgkZgX8eRmYEV2MQ2B-UG1zAn0K6UAuQqxU2QgS0AaFpeiRADU1WGMAOnM-zmNWEGDl_ohDeQCc17xSIMfL6ebgqZeRmZSZmgG3JEGRTdXEOcPXSBBsfDfRHv7Idwg7EYAwuwd58qwaCQbGZokWyYaJKSagbsCqQaW6aYWpqkmqUBxYHVp4mFJIMUbnOk8EnKM3B6hPj6xPt4-nlLM3DBpkEMTWUYWEqKSlNlgbVpSZIcOBgA3GN1UA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MIF+inhibitors&rft.inventor=TAPLEY+PETER+MARK&rft.inventor=MORAND+ERIC+FRANCIS&rft.inventor=LI+XINHUA&rft.inventor=SKENE+COLIN+EDWARD&rft.date=2009-04-15&rft.externalDBID=A&rft.externalDocID=CN101410107A |